Enact Holdings, Inc.
No enriched coverage for $ACT in the last 7 days.
RBC Capital maintained a Hold rating on Enact Holdings (ACT) with a $50.00 price target. Shares closed at $44.90. J.P. Morgan downgraded ACT to Sell. Q2 revenue was $317.31M, net profit $174.84M. Insider sentiment is negative, with recent sales by executives.
JPMorgan downgraded Enact Holdings (ACT) to Underweight, lowering its price target to $44.00. The stock trades at $45.97, above the target and fair value estimates, suggesting overvaluation. JPMorgan cited premium valuation and mixed effects from higher interest rates. Enact reported Q2 2026 earnings beating estimates, with $1.26 EPS and $317.3M revenue. BTIG initiated coverage with a Neutral rating, noting expected ROE declines.
Enact Holdings (Nasdaq: ACT) will release its Q3 2026 earnings on November 4, followed by a conference call on November 5 at 8:00 a.m. ET. The company provides mortgage insurance and is headquartered in Raleigh, North Carolina. Investors can access the earnings materials and webcast via the company's investor relations website.
Recent ACT coverage spans financial news, insider activity and earnings.
In the last 30 days, ACT insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($37.1M). The most active reporter was Genworth Holdings, Inc. with 1 filing.
Analyst downgrade and insider sell pressure likely weigh on the stock.
The downgrade signals valuation concerns and may trigger selling pressure.
The announcement provides a schedule but no financial details, so immediate price impact is expected to be minimal.
The reinsurance deal improves balance‑sheet resilience and may smooth loss volatility, but could cap upside from favorable claim outcomes.
The insider sale suggests potential downside pressure on ACT as a large shareholder reduces stake.
AlphAI scores every news story that mentions ACT with an AI model for sentiment and relevance, and aggregates insider trades from Enact Holdings, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
RBC Capital maintained a Hold rating on Enact Holdings (ACT) with a $50.00 price target. Shares closed at $44.90. J.P. Morgan downgraded ACT to Sell. Q2 revenue was $317.31M, net profit $174.84M. Insider sentiment is negative, with recent sales by executives.
1 min readJPMorgan downgraded Enact Holdings (ACT) to Underweight, lowering its price target to $44.00. The stock trades at $45.97, above the target and fair value estimates, suggesting overvaluation. JPMorgan cited premium valuation and mixed effects from higher interest rates. Enact reported Q2 2026 earnings beating estimates, with $1.26 EPS and $317.3M revenue. BTIG initiated coverage with a Neutral rating, noting expected ROE declines.
1 min readEnact Holdings (Nasdaq: ACT) will release its Q3 2026 earnings on November 4, followed by a conference call on November 5 at 8:00 a.m. ET. The company provides mortgage insurance and is headquartered in Raleigh, North Carolina. Investors can access the earnings materials and webcast via the company's investor relations website.
1 min readEnact Holdings (ACT) announced a quota share reinsurance agreement, ceding 35% of new 2028 insurance to improve balance sheet resilience. The move focuses on long-term risk distribution, not near-term earnings. Current earnings are $683.3M, with analysts forecasting a slight decline to $661.8M by 2029. The decision aims to manage capital needs and loss volatility, potentially influencing valuation and dividends.
3 min readGenworth Holdings, Inc. sold 762,894 shares of Enact Holdings, Inc. (ACT) at $48.65 ($37.12M total) on 2026-09-30.
1 min readEnact Holdings (ACT) secured a reinsurance deal to cede 35% of new insurance written in 2028. The agreement, with A-rated reinsurers, aims to manage risk and stabilize capital. Financial details and impacts on returns were not disclosed.
1 min readEnact Holdings (Nasdaq: ACT) announced a quota share reinsurance agreement with rated reinsurers, ceding 35% of new insurance written in 2028. The deal aims to manage risk and create long-term value, according to CEO Rohit Gupta. Enact is a leading private mortgage insurer.
1 min readGenworth Holdings, Inc. sold 687,379 shares of Enact Holdings, Inc. (ACT) at $49.40 ($33.95M total) on 2026-08-31.
1 min readStolove Evan (EVP, Gen. Counsel & Secretary) sold 20,024 shares of Enact Holdings, Inc. (ACT) at $49.52 ($0.99M total) on 2026-08-17.
1 min readEnact (ACT) reported Q2 2026 adjusted operating income of $177 million, or $1.26 per diluted share, up from $174 million, or $1.15, in Q2 2025. New insurance written rose 15% to $15 billion. FY2026 capital return guidance was raised to $550 million to $600 million. Management cited $274 billion insurance in force and 161% PMIERs sufficiency.
9 min read
